AU Patent

AU2018347583A1 — Methods and compositions for attenuating anti-viral transfer vector IgM responses

Assigned to Cartesian Therapeutics Inc · Expires 2020-05-21 · 6y expired

What this patent protects

Provided herein are methods and related compositions or kits for administering viral transfer vectors in combination with synthetic nanocarriers comprising an immunosuppressant and an anti-IgM agent.

USPTO Abstract

Provided herein are methods and related compositions or kits for administering viral transfer vectors in combination with synthetic nanocarriers comprising an immunosuppressant and an anti-IgM agent.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018347583A1
Jurisdiction
AU
Classification
—
Expires
2020-05-21
Drug substance claim
No
Drug product claim
No
Assignee
Cartesian Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.